- Published at
- by manilatimes.net
positive
positive
News for MaxCyte, Inc. (MXCT.L)
- Published at
- by gurufocus.com
mixedmixedMaxCyte Signs Strategic Platform License with TG Therapeutics to Advance its Autoimmune Cell Therapeutics Programs
TG Therapeutics to use MaxCyte's Flow Electroporation® technology and ExPERTâ„¢ platform to support the development and commercialization of azer-cel, its all- Published at
- by manilatimes.net
positivepositive- Published at
- by gurufocus.com
positivepositiveMaxCyte to Report Fourth Quarter and Full Year 2024 Financial Results on March 11, 2025, and Participate in Upcoming Investor Conference
ROCKVILLE, Md., Feb. 07, 2025 (GLOBE NEWSWIRE) -- MaxCyte, Inc., ( MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform t- Published at
- by manilatimes.net
neutralneutral- Published at
- by manilatimes.net
positivepositive- Published at
- by investing.com
positivepositiveMaxCyte expects growth in core revenue for Q4 and full year 2024 By Investing.com
MaxCyte expects growth in core revenue for Q4 and full year 2024- Published at
- by manilatimes.net
positivepositive- Published at
- by gurufocus.com
positivepositiveMaxCyte Announces Retirement of Board Member Art Mandell
ROCKVILLE, Md., Dec. 22, 2024 (GLOBE NEWSWIRE) -- MaxCyte, Inc., ( MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform t- Published at
- by manilatimes.net
mixedmixed- Published at
- by gurufocus.com
mixedmixedMaxCyte Announces Streamlined Operations and Raises 2024 Revenue Guidance
ROCKVILLE, Md., Dec. 08, 2024 (GLOBE NEWSWIRE) -- MaxCyte, Inc., ( MXCT; LSE: MXCT), a leading cell-engineering focused company providing enabling platform te- Published at
- by investing.com
neutralneutralMaxCyte stock touches 52-week low at $3.23 amid market challenges By Investing.com
MaxCyte stock touches 52-week low at $3.23 amid market challenges- Published at
- by insidermonkey.com
positivepositiveMaxCyte, Inc. (NASDAQ:MXCT) Q3 2024 Earnings Call Transcript
Operator: Hello and welcome to MaxCyte Third Quarter Earnings Conference Call. At this time, all participants are in a listen-only mode.- Published at
- by gurufocus.com
positivepositiveMaxCyte Inc (MXCT) Q3 2024 Earnings Call Highlights: Strong Core Revenue Growth Amidst Market Challenges
Total Revenue: $8.2 million in Q3 2024, a 2% increase from $8 million in Q3 2023.Core Revenue: $8.1 million, up 23% from $6.6 million in the prior year quarter- Published at
- by gurufocus.com
positivepositiveQ3 2024 MaxCyte Inc Earnings Call Transcript
Nov 06, 2024 / 09:30PM GMTOperator Third quarter earnings conference call. At this time. All participants are in listen-only mode. After the speaker presentatio- Published at
- by globenewswire.com
positivepositiveMaxCyte Signs Strategic Platform License with Kamau Therapeutics to Accelerate the Development of Cell Therapies for Genetic Diseases
Kamau to use MaxCyte’s Flow Electroporation® technology and ExPERT™ platform to support its homology-directed repair (HDR) novel gene correction technology...- Published at
- by globenewswire.com
neutralneutralTransfection Technologies Market to Grow at CAGR of 9% through 2033 - Rapid Advancements in Biology and Medicine
The global transfection technologies market size is anticipated to grow from USD 2 billion to USD 4.73 billion in 10 years. The market will experience...- Published at
- by benzinga.com
mixedmixedWhy Upstart Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session - Upstart Hldgs (NASDAQ:UPST)
Loading... Loading... Shares of Upstart Holdings, Inc. UPST fell sharply during Wednesday's session after the company reported first-quarter financial results ...ZIVST.MXVST-WTAVSTTWLO.MXTWLOTRIP.MXTRIP.BATRIPT6A.DET1WL34.SASWIMSTAASHLSRPTXPWSCOPK.TAOPK.MXOPKMYGNMYD.DEMXCT.LMXCL.LMAXCLYFT.MXLYFTLY0.DELPXLEUISUNINODHYHASIGMED.MXGMEDELANDVCRCTCPNGCLOVWCLOVARKOWARKO.TAARKOAPEIAOSLN.MXAOSLAMRKAMRC0QZS.L0LHL.L0KCS.L0K3W.L0A8O.L0A70.LUT8.DEUPSTUBER.MXUBERU1BE34.SATMCITEVJFTEVA.TATEVASMLRSIGASHOPN.MXSHOP.TOSHOP.BASHOPSATSS2HO34.SARPDRNG.MXRNGQLYSMCRBMASI.MXMASILZINSPGODHCRUS.MXCRUSAFRM.MXAFRMAFIBABNB0VHA.L0V50.L0KTX.L0JZ2.L0HYI.LVEO.DEVECOLAZR.MXLAZR- Published at
- by medium.com
mixedmixedCell Therapy Technologies Market: Projected to Reach US$ 19.6 Billion by 2033
According to a recently released Fact.MR analysis, the global market for Cell Treatment Technologies is expected to generate US$ 4.5 billion in revenue in 2022 and is predicted to expand at a CAGR of…- Published at
- by benzinga.com
mixedmixedHarrow Posts Weak Q4 Results, Joins TeraWulf, Nasdaq And Other Big Stocks Moving Lower In Wednesday’s Pre-Market Session - TeraWulf (NASDAQ:WULF), Nasdaq (NASDAQ:NDAQ), Harrow (NASDAQ:HROW)
U.S. stock futures were slightly lower this morning, with the Dow futures falling by around 0.1% on Wednesday.